• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    CorMedix, Inc. (CRMD)

    -NYSE MKT
    1.54 Up 0.14(10.00%) 4:10PM EST
    Add to Portfolio
    ProfileGet Profile for:
    CorMedix, Inc.
    745 Route 202-206
    Suite 303
    Bridgewater, NJ 08807
    United States - Map
    Phone: 908-517-9500
    Website: http://www.cormedix.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Biotechnology
    Full Time Employees:2

    Business Summary 

    CorMedix Inc., a development-stage pharmaceutical and medical device company, intends to in-license, develop, and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases. The company’s product candidates include CRMD003 (Neutrolin) and CRMD004, an antimicrobial/antifungal and anticoagulant combination in liquid and gel formulations used for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on CorMedix, Inc.

    Key Executives 
     PayExercised
    Mr. Randy D. Milby MBA, 60
    Chief Exec. Officer and Director
    223.00K0.00
    Dr. Antony E. Pfaffle M.D., 50
    Vice Chairman, Chief Scientific Officer, Director and Chairman of Compensation Committee
    195.00K0.00
    Mr. Harry O'Grady ,
    Chief Financial Officer
    N/AN/A
    Dr. William J. Vanjonack Ph.D.,
    VP of Manufacturing & Quality Operations
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders